TCMD (Tactile Systems Technology) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 09, 2026)


TCMD Tactile Systems Technology Inc TCMD
74 GF Score
Price $30.64
GF Value $18.74
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Tactile Systems Technology 5-Year Yield-on-Cost %?

Tactile Systems Technology TCMD +2.33% 74 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus rates TCMD with a GF Score™ of 74/100 and a GF Value™ of $18.74 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Tactile Systems Technology ranks worse than 305810.09% on this metric.

Tactile Systems Technology's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Tactile Systems Technology's 5-Year Yield-on-Cost % or its related term are showing as below:



TCMD's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.39
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Tactile Systems Technology  (NAS:TCMD) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Tactile Systems Technology 5-Year Yield-on-Cost % Related Terms


TCMD vs SSII, BVS, BBNX: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, Tactile Systems Technology's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tactile Systems Technology 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's 5-Year Yield-on-Cost % falls into.


TCMD
74GF Score
Tactile Systems Technology Inc TCMD
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tactile Systems Technology 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Tactile Systems Technology is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Tactile Systems Technology (TCMD) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tactile Systems Technology and its competitors. According to the industry distribution chart, Tactile Systems Technology ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is Tactile Systems Technology's 5-Year Yield-on-Cost % too high?
Tactile Systems Technology's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Tactile Systems Technology ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tactile Systems Technology has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tactile Systems Technology's 5-Year Yield-on-Cost % compare to SSII and BVS?
According to the Medical Devices & Instruments industry distribution chart, Tactile Systems Technology ranks #999999 out of 327 companies for 5-Year Yield-on-Cost %. This places Tactile Systems Technology in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.39, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Tactile Systems Technology and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tactile Systems Technology's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tactile Systems Technology stock overvalued right now?
Based on GuruFocus' analysis, Tactile Systems Technology (TCMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.74, compared to a current price of $30.64 — trading 63.5% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Tactile Systems Technology's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Tactile Systems Technology (TCMD), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tactile Systems Technology (TCMD) Overvalued in 2026?

Based on GuruFocus' analysis, Tactile Systems Technology stock appears to be overvalued. The current stock price of $30.64 is trading 63.5% above its estimated GF Value™ of $18.74. GuruFocus considers Tactile Systems Technology to be Significantly Overvalued.

Key valuation signals for TCMD:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $18.74 vs. price of $30.64 (63.5% above fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the TCMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tactile Systems Technology Business Description

Other Exchanges 3L3:Germany
Address 3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
74GF Score

Get the complete analysis for TCMD

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.64
Price
$18.74
GF Value